ENTPD1 and cancer: In cancer cell lines (bladder, colorectal, prostate and breast) exosomes expressing CD39 and CD73 ectonucleotidases have been described that can indirectly modulate the effector immune cells activity in the tumor environment as a mechanism of Treg cell-mediated immune regulation, [51].